Latest Safety News

WA Kaolin Limited has reported a remarkable surge in sales volumes and revenue for the September 2025 quarter, driven by operational upgrades and expanding market reach. The company’s forward orders and product diversification signal robust growth ahead.

Nova Eye Medical reported a robust 32% increase in global sales excluding China for Q1 FY26 and secured regulatory approval for its iTrack™ Advance device in China, setting the stage for expanded market penetration.

Robex Resources reports strong Q3 2025 progress with Kiniero Gold Project on track for Q4 first gold pour, raises C$148 million via accelerated warrant exercise, and announces merger plans with Predictive Discovery.

Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.

MC Mining reports strong safety performance and steady progress on its flagship Makhado coal project, while Uitkomst Colliery implements a turnaround plan amid production setbacks. Cash reserves have strengthened following significant share subscription payments.

Geopacific Resources advances its Woodlark Gold Project with promising drilling results at Kamwak and a crucial mining lease extension, while strengthening strategic partnerships and progressing its feasibility study.

Vectus Biosystems has signed a binding agreement to sell its VB4-P5 renal fibrosis compound to Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its lead drug VB0004 and others, particularly in China.

AJ Lucas Group Limited reported a robust start to FY26, driven by a significant UK dispute settlement and improved Australian operations. The company’s liquidity and operational upgrades position it well despite ongoing challenges.

Peninsula Energy has achieved a significant operational milestone with its first dried yellowcake production at the Lance Uranium Operation, while revising its near-term production guidance and completing a major equity raise to support growth.

First Graphene Limited has reported its strongest first quarter sales ever for its PureGRAPH products, alongside new product launches and strategic partnerships that position it at the forefront of advanced materials innovation.

Biotron Limited has advanced its Hepatitis B antiviral program while preparing to acquire Sedarex Limited, backed by a $2.5 million capital raise. The move signals a strategic expansion into safer anaesthetics alongside ongoing R&D progress.

Kingsgate Consolidated Ltd reported a record September quarter at its Chatree Gold Mine, with gold production surging 18% to nearly 24,000 ounces and silver output exceeding 200,000 ounces. Strong metal prices and operational efficiencies lifted cash and bullion holdings to A$115 million.